Journey Medical (DERM) Treasury Shares (2020 - 2026)

Journey Medical's Treasury Shares history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• Quarterly Treasury Shares fell 25.34% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 25.34% YoY) and the FY2025 annual result came in at $1.8 million, down 21.02% from the prior year.
• Treasury Shares was $1.7 million for Q1 2026 at Journey Medical, down from $1.8 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.7 million in Q2 2024 and bottomed at $1.3 million in Q4 2023.
• A 5-year average of $2.0 million and a median of $1.9 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 238.96% — and 2023, when it sank 43.13%.
• Journey Medical's Treasury Shares stood at $2.3 million in 2022, then sank by 42.2% to $1.3 million in 2023, then soared by 79.04% to $2.3 million in 2024, then retreated by 21.02% to $1.8 million in 2025, then retreated by 7.91% to $1.7 million in 2026.
• Business Quant data shows DERM's Treasury Shares at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.